Curasan

What Curasan does

Curasan Inc. is the US-Canadian commercial subsidiary of German medical technology company curasan AG, founded in 1988 and headquartered in Frankfurt am Main, Germany, with a North American regional headquarters in Wake Forest, North Carolina. The company develops, manufactures, and distributes biomaterials for bone and tissue regeneration across two principal verticals: dental biomaterials and orthobiologics. Its product portfolio spans dental bone graft substitutes (CERASORB M, CERASORB Bioactive, OSBONE hydroxyapatite, ALLOSORB allograft), resorbable membranes (EPI-GUIDE PLA membrane, CollaGuide), adjunct products (OsteoSelect DBM Putty, OsteoWrap, HealiAid wound dressing), and orthobiologic solutions for spine and orthopedic surgery (CERACELL Ortho Foam, CERASORB M as a graft extender).

The underlying technology is built on phase-pure (>99%) beta-tricalcium phosphate (β-TCP) with interconnected multi-porosity for predictable osteoclast-mediated resorption, combined with collagen matrices and a proprietary D,D-L,L-polylactic acid three-layer membrane architecture providing extended barrier function (approximately 20 weeks) for guided tissue and bone regeneration. CERACELL Ortho Foam adds silicate (4%) to silicated β-TCP embedded in porcine collagen foam to promote osteointegration in posterolateral fusion procedures, where a 13-patient study reported 100% fusion success at 12-month follow-up.

Curasan monetizes through one-time medical device sales into two separate authorized-distributor networks (dental and orthopedic) in the US and Canada, with quote-based pricing and no publicly disclosed list prices. End customers are primarily dental professionals (dentists, oral surgeons, periodontists, implantologists) and orthopedic/spine surgeons needing graft substitutes, graft extenders, and resorbable membranes. The company markets through its website, distributor portals, clinical case study books, and a professional B2B content program emphasizing 25+ years of clinical heritage.

Name

Curasan

Legal name

curasan Inc.

Website

https://curasaninc.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

Curasan Inc. is the US-Canadian subsidiary of German parent curasan AG, manufacturing and distributing biosynthetic bone graft substitutes, resorbable membranes, and orthobiologic biomaterials for dental professionals and orthopedic/spine surgeons across the US and Canada.

Ownership category

akta.pro rank

Product category

Dental & Orthopedic Biomaterials

NAICS

Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Dental Implant Surgery & Bone Grafting (HLABAEAB), Periodontal Regeneration (GTR/EMD/Biologics) (HLABACAI)

Keywords

• Dental biomaterials
• Bone graft substitutes
• Orthobiologic products
• Tissue regeneration materials
• Resorbable membranes

Headquarters

HQ city

Flörsheim Am Main

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales - Dental Biomaterials: Sale of biosynthetic bone graft substitutes, membranes, and regenerative products for dental applications including CERASORB, OSBONE, ALLOSORB, EPI-GUIDE, CollaGuide, and other dental biomaterials.
2. Medical Device Sales - Orthobiologics: Sale of orthobiologic products for orthopedic, spine, and traumatology applications including CERASORB M, CERACELL Ortho Foam, and related bone regeneration solutions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Curasan develops, manufactures, and distributes biosynthetic bone graft substitutes, resorbable polymer membranes, collagen-based matrices, and demineralized bone matrix (DBM) products for bone and tissue regeneration. The portfolio is organized into two product lines — Dental Biomaterials (e.g., CERASORB M, CERASORB Bioactive, EPI-GUIDE, CollaGuide) and Orthobiologics (e.g., OSBONE, ALLOSORB, OsteoSelect DBM Putty, OsteoWrap, HealiAid, CERACELL Ortho Foam) — and is sold to licensed dental and orthopedic professionals through a distributor network across the US and Canada.

Product overview

Curasan is a medical technology company specializing in bone and tissue regeneration solutions, operating through two main product portfolios: Dental Biomaterials and Orthobiologics. The Dental Biomaterials portfolio includes CERASORB® family products (CERASORB® Bioactive, CERASORB® M), ALLOSORB® allograft, OSBONE® synthetic hydroxyapatite, EPI-GUIDE® resorbable PLA membrane, CollaGuide® collagen membrane, OsteoSelect® DBM Putty, OsteoWrap®, and HealiAid® wound dressing. The Orthobiologics portfolio features CERACELL® Ortho Foam (silicated β-TCP collagen foam) and CERASORB® M for orthopedic and spine applications. Together, these products provide comprehensive solutions for bone regeneration across dental, orthopedic, spine, and traumatology procedures.

Differentiator

Problem solved

Functional benefit

Brands

• CERASORB: Bone graft substitute product umbrella brand including CERASORB M and CERASORB Bioactive variants for bone regeneration
• CERACELL
• EPI-GUIDE
• OSBONE
• ALLOSORB
• HealiAid
• OsteoSelect
• OsteoWrap
• CollaGuide

Products and services

• CERASORB M Resorbable β-TCP bone graft substitute used by dental professionals for bone augmentation, socket preservation, and implantology procedures.
• CERASORB Bioactive Bioactive bone graft substitute for dental applications, leveraging silicated β-TCP technology combined with collagen foam to support bone regeneration in dental surgical procedures.
• EPI-GUIDE Resorbable PLA-based barrier membrane used in dental guided tissue/bone regeneration (GTR/GBR) procedures performed by dental professionals.
• CollaGuide Collagen-based resorbable membrane for dental guided tissue regeneration procedures, used by dental professionals in periodontal and implant surgery.
• OSBONE Synthetic bone graft substitute for orthopedic bone void filling and fusion procedures, used by orthopedic and spine surgeons.
• ALLOSORB Allograft bone graft substitute used in orthopedic and spine surgical procedures for bone regeneration and fusion.
• OsteoSelect DBM Putty Demineralized bone matrix (DBM) putty for orthopedic bone void filling and fusion procedures, sold to orthopedic and spine surgeons through authorized distributors.
• OsteoWrap Orthopedic bone graft wrap used by orthopedic surgeons in bone regeneration and fusion procedures.
• HealiAid Orthobiologic healing-aid product used by surgical professionals to support soft-tissue and bone healing in orthopedic procedures.
• CERACELL Ortho Foam Composite orthobiologic foam combining silicated β-TCP with collagen, used in orthopedic bone regeneration and fusion procedures.

Quantifiable outcome

• 100% fusion success rate at 12-month follow-up in CERACELL Ortho Foam posterolateral fusion study (13 patients, ages 37-83)

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• ZimVie (formerly Biomet 3i): Spun off from Zimmer Biomet with a dedicated dental and spine regenerative portfolio (RegenerOss, Puros allograft), directly competing with both Curasan's dental biomaterials and orthobiologic/spine lines.
• Osteogenics Biomedical: Specialty dental regenerative company offering Cytoplast PTFE membranes, bone grafting materials, and wound dressing products that overlap directly with Curasan's EPI-GUIDE, CERASORB, and HealiAid portfolios.
• Geistlich Pharma: Swiss market leader in dental bone regeneration with Bio-Oss (bovine bone) and Bio-Gide collagen membrane, directly competing with Curasan's CERASORB, OSBONE, and EPI-GUIDE in dental implantology and GBR/GTR procedures.
• RTI Surgical: Orthobiologic and allograft company offering bone graft substitutes and sports medicine implants, directly comparable to Curasan's ALLOSORB, OsteoSelect DBM Putty, and CERACELL orthopedic lines.
• LifeNet Health: Non-profit allograft and biologics provider with dental and orthopedic bone graft substitutes; directly comparable to Curasan's ALLOSORB and OsteoSelect DBM product lines as an allograft supplier.

Broad incumbents

• Medtronic: Spine and orthopedic giant with a broad orthobiologics portfolio (INFUSE, Grafton DBM); competes with Curasan's CERACELL Ortho Foam and CERASORB M in spinal fusion and orthopedic reconstruction.
• Straumann Group: Global dental implant leader that has expanded into regenerative dentistry (via botiss and other acquisitions); competes with Curasan in bone augmentation and membranes around implant placement.
• Dentsply Sirona: Global dental equipment and materials incumbent with regenerative and implant product lines; serves the same dental professionals as Curasan but across a much broader portfolio including chairs, imaging, and CAD/CAM.
• Stryker: Diversified orthopedic and spine company with orthobiologic products used in trauma and spine fusion; competes with Curasan in the same surgical settings for bone graft extender applications.
• NuVasive (now Globus Medical): Spine-focused medical device company with proprietary orthobiologic offerings (AttraX, Osteocel) that overlap with Curasan's CERACELL and CERASORB M positioning in spinal fusion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/curasanAG
• LinkedInlinkedin.com/company/curasan-ag

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curasan